Publicado —
Produced by O Som e a Fúria (Portugal) and Norte Productions (France) and promoted internationally by AGENCIA - Portuguese Short Film Agency, the film confronts images of a solar eclipse day in Lisbon and excerpts from a poem by Henri Michaux, read by French actress Delphine Seyrig.
“Sol Negro” is part of the TIFF's Wavelengths section, an exclusive avant-garde film section that highlights formal innovation and original cinematic expressions in the context of one of the world's largest and busiest film festivals. The programmers define the film on the festival's webpage: "Underscored by French film legend Delphine Seyrig’s evocative recitation of a Henri Michaux poem, Maureen Fazendeiro’s film is a mysterious, multi-textured portrait of eclipse spectators in Portugal".
“Sol negro is my first film totally made in Portugal, the country I came to live in 2014 - says Maureen Fazendeiro - In March 2015, I gathered a small team, borrowed a camera and, using 16mm black and white film leftovers, I filmed the total eclipse of the sun, visible at 67% at the Lisbon's Astronomical Observatory. That day I collected a series of portraits of amazed spectators. When in 2019, I got financed for post-production, I was able to resume the editing interrupted for almost four years. It was about archeology of a film, made from fragments of images and sounds collected over time. I remembered a poem by Henri Michaux that speaks of an imagined country where there is only one sun per month, an event that creates a certain excitement in its inhabitants. ”
After “Motu Maeva”, DocLisboa award-winning documentary, “Sol Negro” is Maureen Fazendeiro's second film, which had its world premiere last July at the Curtas Vila do Conde International Film Festival competition.
Outras Notícias
Curtas Vila do Conde
Festival
Contactos
Curtas Vila do Conde
Festival Internacional de Cinema
Praça José Régio, 110
4480-718 Vila do Conde
Portugal
T +351 25 2646516 / 252 643386 (chamada para a rede fixa nacional)
E-mail: info@curtas.pt
© 2024 Curtas Metragens, CRL
Subscrever Newsletter
Back